Cargando…
Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548076/ https://www.ncbi.nlm.nih.gov/pubmed/37291833 http://dx.doi.org/10.14802/jmd.23057 |
_version_ | 1785115198168760320 |
---|---|
author | Desjardins, Clément Nilles, Christelle Devos, David Roze, Emmanuel |
author_facet | Desjardins, Clément Nilles, Christelle Devos, David Roze, Emmanuel |
author_sort | Desjardins, Clément |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10548076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Korean Movement Disorder Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-105480762023-10-05 Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option? Desjardins, Clément Nilles, Christelle Devos, David Roze, Emmanuel J Mov Disord Letter to the Editor The Korean Movement Disorder Society 2023-09 2023-06-09 /pmc/articles/PMC10548076/ /pubmed/37291833 http://dx.doi.org/10.14802/jmd.23057 Text en Copyright © 2023 The Korean Movement Disorder Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Desjardins, Clément Nilles, Christelle Devos, David Roze, Emmanuel Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option? |
title | Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option? |
title_full | Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option? |
title_fullStr | Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option? |
title_full_unstemmed | Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option? |
title_short | Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option? |
title_sort | apomorphine monotherapy for parkinson’s disease: a neglected option? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548076/ https://www.ncbi.nlm.nih.gov/pubmed/37291833 http://dx.doi.org/10.14802/jmd.23057 |
work_keys_str_mv | AT desjardinsclement apomorphinemonotherapyforparkinsonsdiseaseaneglectedoption AT nilleschristelle apomorphinemonotherapyforparkinsonsdiseaseaneglectedoption AT devosdavid apomorphinemonotherapyforparkinsonsdiseaseaneglectedoption AT rozeemmanuel apomorphinemonotherapyforparkinsonsdiseaseaneglectedoption |